US 9803205
Compositions and methods for inhibiting gene expression of factor XII
granted A61KA61K31/713A61K45/06
Quick answer
US patent 9803205 (Compositions and methods for inhibiting gene expression of factor XII) held by Arrowhead Pharmaceuticals, Inc. expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/42, A61K47/554